Search Options Stock News and Analysis

https://www.schaeffersresearch.com/content/news/2020/05/29/eli-lilly-stock-soars-on-fda-approval

5/29/2020 10:45 AM

The shares of Eli Lilly (NYSE: LLY) are up 0.3% to trade at $150.22 this morning, after the Food and Drug Administration (FDA) approved the use of TAUVID, the first radioactive agent to detect an ab...

LLY Stock Inching Towards Record High Ahead of Earnings

https://www.schaeffersresearch.com/content/analysis/2020/04/22/lly-stock-inching-towards-record-high-ahead-of-earnings

4/22/2020 1:49 PM

Pharmaceutical concern Eli Lilly and Co (NYSE:LLY) is trading back within a chip shot of its April 20, record closing high of $157.79. The equity is up 2.2% at $156.05 as investors gear up for the co...

The Week That Brought the Dow to Its Knees

https://www.schaeffersresearch.com/content/news/2020/03/13/the-week-that-brought-the-dow-to-its-knees

3/13/2020 3:17 PM

Triggering yet another whirlwind week on Wall Street, coronavirus fears continue to rise, as a rapid increase in cases both worldwide and within the U.S. shake investors. Markets began the week with...

Drug Stock Upgraded Despite Coronavirus Threat

https://www.schaeffersresearch.com/content/news/2020/03/11/drug-stock-upgraded-despite-coronavirus-threat

3/11/2020 11:02 AM

Eli Lilly and Co (NYSE:LLY) is up 0.3% to trade at $140.81 at last check, shaking off the broader market sell-off thanks to some bullish analyst attention. The drug manufacturer was just added to the ...

Study Fail Knocks LLY Stock Lower

https://www.schaeffersresearch.com/content/news/2019/10/16/study-fail-knocks-lly-stock-lower

10/16/2019 9:44 AM

The shares of Eli Lilly and Co (NYSE:LLY) are slipping today, thanks to a failed late-stage study of its pancreatic cancer treatment. The trial studied the effects of pegilodecakin combined with chem...

PEOPLE ALSO SEARCH FOR